Key result
Quinidine therapy decreased renal clearance of digoxin from 1.19 to 0.86 ml/min/kg and extrarenal clearance from 0.85 to 0.49 ml/min/kg.
Why the study?
Does quinidine therapy alter steady-state digoxin pharmacokinetics in cardiac patients on long-term digoxin?
Does quinidine therapy alter steady-state digoxin pharmacokinetics in cardiac patients on long-term digoxin?
Quinidine significantly alters digoxin pharmacokinetics by decreasing both renal and extrarenal clearance and increasing half-life, highlighting a critical drug-drug interaction.
Answers are grounded in this paper and cite their sources.
Quinidine may reduce digoxin clearance in cardiac patients; this Level 3 cohort finding leaves open the need for prospective confirmation before guiding therapy.
In seven cardiac patients on long-term digoxin therapy, digoxin kinetics were investigated - in the absence and presence of quinidine - after simultaneous administration of an oral digoxin dose and an intravenous 3H-digoxin bolus injection. From 3H-digoxin data quinidine was found to decrease both renal (from 1.19 +/- 0.35 to 0.86 +/- 0.21 ml/min./kg) (P less than 0.02) and extrarenal clearances of digoxin (from 0.85 +/- 0.24 to 0.49 +/- 0.23 ml/min./kg) (P less than 0.02), and to diminish the steady state distribution volume of the drug (from 6.78 +/- 1.23 to 5.63 +/- 1.64 l/kg) (P less than 0.02). Plasma half-life increased from 51.5 +/- 5.4 to 64.4 +/- 14.8 hrs (P less than 0.05), while urinary excretion half-life increased from 54.4 +/- 3.9 to 78.5 +/- 14.1 hrs (P less than 0.01). Pharmacokinetic parameters derived from plasma and urinary digoxin data showed similar changes during quinidine therapy. Reduction in renal 3H-digoxin clearance occurred at subtherapeutic plasma quinidine levels and was independent of plasma quinidine, whereas reductions in extrarenal 3H-digoxin clearance and 3H-digoxin distribution volume were positively correlated to plasma quinidine concentrations (P less than 0.05).
No takes yet. Share an insight, caveat, or question.
Pedersen et al. (1983) studied Cardiac patients on long-term digoxin therapy (n=7). Quinidine vs. Absence of quinidine was evaluated on Renal clearance of digoxin (ml/min/kg) (p=<0.02). Quinidine therapy decreased renal clearance of digoxin from 1.19 to 0.86 ml/min/kg and extrarenal clearance from 0.85 to 0.49 ml/min/kg.
Synapse has enriched 10 related papers. Consider them for comparative context: